At its meeting on 23 January 2023, the Transparency Coucil adopted Position No. 13/2023 on the evaluation of Apexxnar vaccine for the indication: prevention of pneumococcal infections in adults over 65 years of age.
At its meeting on 23 January 2023, the Transparency Coucil adopted Position No. 13/2023 on the evaluation of Apexxnar vaccine for the indication: prevention of pneumococcal infections in adults over 65 years of age.